Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2020 08:00 ET | Source: Gritstone Oncology, Inc

Gritstone Oncology to Present Clinical Data from Ongoing GRANITE and SLATE Phase 1 Studies During Investor Webcast on July 13

EMERYVILLE, Calif., June 24, 2020 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight...
June 10, 2020 08:00 ET | Source: Gritstone Oncology, Inc

Gritstone Oncology Announces the Addition of Jean-Charles Soria, M.D., Ph.D., to its Scientific Advisory Board

EMERYVILLE, Calif., June 10, 2020 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to...
June 04, 2020 08:00 ET | Source: Gritstone Oncology, Inc

Gritstone Oncology to Present at Two Upcoming Investor Conferences in June

EMERYVILLE, Calif., June 04, 2020 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight...
May 07, 2020 09:01 ET | Source: Gritstone Oncology, Inc

Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights

EMERYVILLE, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight...
May 01, 2020 08:00 ET | Source: Gritstone Oncology, Inc

Gritstone Oncology Announces the Appointment of Dr. Elaine V. Jones as Chair of the Board of Directors

EMERYVILLE, Calif., May 01, 2020 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight...
April 06, 2020 08:00 ET | Source: Gritstone Oncology, Inc

Gritstone Oncology Announces the Appointment of Veteran Legal Executive Rahsaan Thompson as General Counsel

EMERYVILLE, Calif., April 06, 2020 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to...
March 11, 2020 09:01 ET | Source: Gritstone Oncology, Inc

Gritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights

EMERYVILLE, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to...
February 25, 2020 16:00 ET | Source: Gritstone Oncology, Inc

Gritstone Oncology to Present at Two Investor Conferences in March

EMERYVILLE, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight...
January 08, 2020 16:00 ET | Source: Gritstone Oncology, Inc

Gritstone Oncology to Present at the 38th Annual J.P. Morgan Healthcare Conference

EMERYVILLE, Calif., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight...
December 12, 2019 05:05 ET | Source: Gritstone Oncology, Inc

Gritstone Oncology Reports Promising Early Immunogenicity Activity and Safety Data from its Phase 1 Studies Evaluating its Neoantigen-based Immunotherapies, GRANITE and SLATE

-- Preliminary results demonstrate unprecedented levels of primed CD8+ neoantigen-specific cytotoxic T cells and expansion of pre-existing T cells even in low-dose cohorts ---- Investor conference...